Influences of dopaminergic lesion on epidermal growth factor‐ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons
- 22 April 2005
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 93 (4), 974-983
- https://doi.org/10.1111/j.1471-4159.2005.03073.x
Abstract
Epidermal growth factor (EGF) is a member of a structurally related family containing heparin-binding EGF-like growth factor (HB-EGF) and transforming growth factor alpha (TGFalpha) that exerts neurotrophic activity on midbrain dopaminergic neurons. To examine neurotrophic abnormality in Parkinson's disease (PD), we measured the protein content of EGF, TGFalpha, and HB-EGF in post-mortem brains of patients with Parkinson's disease and age-matched control subjects. Protein levels of EGF and tyrosine hydroxylase were decreased in the prefrontal cortex and the striatum of patients. In contrast, HB-EGF and TGFalpha levels were not significantly altered in either region. The expression of EGF receptors (ErbB1 and ErbB2, but not ErbB3 or ErbB4) was down-regulated significantly in the same forebrain regions. The same phenomenon was mimicked in rats by dopaminergic lesions induced by nigral 6-hydroxydopamine infusion. EGF and ErbB1 levels in the striatum of the PD model were markedly reduced on the lesioned side, compared with the control hemisphere. Subchronic supplement of EGF in the striatum of the PD model locally prevented the dopaminergic neurodegeration as measured by tyrosine hydroxylase immunoreactivity. These findings suggest that the neurotrophic activity of EGF is maintained by afferent signals of midbrain dopaminergic neurons and is impaired in patients with Parkinson's disease.Keywords
This publication has 55 references indexed in Scilit:
- Regulation of the Development of Mesencephalic Dopaminergic Systems by the Selective Expression of Glial Cell Line-Derived Neurotrophic Factor in Their TargetsJournal of Neuroscience, 2004
- Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patientsMolecular Psychiatry, 2002
- The erbB/HER type 1 tyrosine kinase receptor familyThe Journal of Pathology, 1998
- Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer researchBreast Cancer Research and Treatment, 1995
- Growth factors in Parkinson's diseaseProgress in Growth Factor Research, 1994
- Epidermal Growth Factor and Basic Fibroblast Growth Factor Have Independent Actions on Mesencephalic Dopamine Neurons in CultureJournal of Neurochemistry, 1994
- Enhanced recovery of the nigrostriatal dopaminergic system in MPTP-treated mice following intrastriatal injection of basic fibroblast growth factor in relation to agingBrain Research, 1993
- Localization of immunoreactive epidermal growth factor receptors in human nervous system.Journal of Histochemistry & Cytochemistry, 1988
- Evaluation of Parkinson’s Disease: Reliability of Three Rating ScalesNeuroepidemiology, 1987
- Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsNature, 1984